Experience in <scp>IVI</scp>g Therapy for Selected Women with Recurrent Reproductive Failure and <scp>NK</scp> Cell Expansion

Abstract

Immunomodulation with IVIg in our selected group of RRF patients with immunologic alterations enhanced clinical pregnancy and live birth rates. Our results may facilitate the design of future clinical trials of IVIg in this pathology.